The Role of Micronutrients in Heart Failure

      Abstract

      Heart failure is a common condition in the Western world, particularly among elderly persons and with an ever-aging population, the incidence is expected to increase. Diet in the setting of heart failure is important—patients with this condition are advised to consume a low-salt diet and monitor their weight closely. Nutritional status of patients with heart failure also is important—those with poor nutritional status tend to have a poor long-term prognosis. A growing body of evidence suggests an association between heart failure and micronutrient status. Reversible heart failure has been described as a consequence of severe thiamine and selenium deficiency. However, contemporary studies suggest that a more subtle relationship may exist between micronutrients and heart failure. This article reviews the existing literature linking heart failure and micronutrients, examining studies that investigated micronutrient intake, micronutrient status, and the effect of micronutrient supplementation in patients with heart failure, and focusing particularly on vitamin A, vitamin C, vitamin E, thiamine, other B vitamins, vitamin D, selenium, zinc, and copper.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dickstein K.
        • Cohen-Solal A.
        • Filippatos G.
        • et al.
        ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.
        Eur J Heart Fail. 2008; 10: 933-989
        • Lloyd-Jones D.M.
        • Larson M.G.
        • Leip E.P.
        • et al.
        Lifetime risk for developing congestive heart failure: The Framingham Heart Study.
        Circulation. 2002; 106: 3068-3072
        • Roger V.L.
        • Go A.S.
        • Lloyd-Jones D.M.
        • et al.
        Heart disease and stroke statistics—2011 update: A report from the American Heart Association.
        Circulation. 2011; 123: e18-e209
        • Lloyd-Jones D.
        • Adams R.J.
        • Brown T.M.
        • et al.
        Heart disease and stroke statistics—2010 update: A report from the American Heart Association.
        Circulation. 2010; 121: e46-e215
        • Levy D.
        • Kenchaiah S.
        • Larson M.G.
        • et al.
        Long-term trends in the incidence of and survival with heart failure.
        N Engl J Med. 2002; 347: 1397-1402
        • Anker S.D.
        • Ponikowski P.
        • Varney S.
        • et al.
        Wasting as independent risk factor for mortality in chronic heart failure.
        Lancet. 1997; 349: 1050-1053
        • von Haehling S.
        • Doehner W.
        • Anker S.D.
        Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
        Cardiovasc Res. 2007; 73: 298-309
        • Woodside J.V.
        • McCall D.
        • McGartland C.
        • Young I.S.
        Micronutrients: Dietary intake v. supplement use.
        Proc Nutr Soc. 2005; 64: 543-553
        • Evans P.
        • Halliwell B.
        Micronutrients: Oxidant/antioxidant status.
        Br J Nutr. 2001; 85: S67-S74
        • Li Y.C.
        • Qiao G.
        • Uskokovic M.
        • Xiang W.
        • Zheng W.
        • Kong J.
        Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure.
        J Steroid Biochem Mol Biol. 2004; 89-90: 387-392
        • Jessup M.
        • Abraham W.T.
        • Casey D.E.
        • et al.
        2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation.
        Circulation. 2009; 119: 1977-2016
        • Lindenfeld J.
        • Albert N.M.
        • et al.
        • Heart Failure Society of America
        HFSA 2010 Comprehensive Heart Failure Practice Guideline.
        J Card Fail. 2010; 16: e1-e194
        • Soukoulis V.
        • Dihu J.B.
        • Sole M.
        • et al.
        Micronutrient deficiencies an unmet need in heart failure.
        J Am Coll Cardiol. 2009; 54: 1660-1673
        • de Lorgeril M.
        • Salen P.
        • Accominotti M.
        • et al.
        Dietary and blood antioxidants in patients with chronic heart failure.
        Eur J Heart Fail. 2001; 3: 661-669
        • Gorelik O.
        • Almoznino-Sarafian D.
        • Feder I.
        • et al.
        Dietary intake of various nutrients in older patients with congestive heart failure.
        Cardiology. 2003; 99: 177-181
        • Price R.J.
        • Witham M.D.
        • McMurdo M.E.
        Defining the nutritional status and dietary intake of older heart failure patients.
        Eur J Cardiovasc Nurs. 2007; 6: 178-183
        • Catapano G.
        • Pedone C.
        • Nunziata E.
        • Zizzo A.
        • Passantino A.
        • Incalzi R.A.
        Nutrient intake and serum cytokine pattern in elderly people with heart failure.
        Eur J Heart Fail. 2008; 10: 428-434
        • Arcand J.
        • Floras V.
        • Ahmed M.
        • et al.
        Nutritional inadequacies in patients with stable heart failure.
        J Am Diet Assoc. 2009; 109: 1909-1913
        • Lourenco B.H.
        • Vieira L.P.
        • Macedo A.
        • et al.
        Nutritional status and adequacy of energy and nutrient intakes among heart failure patients.
        Arq Bras Cardiol. 2009; 93: 541-548
        • Lemon S.C.
        • Olendzki B.
        • Magner R.
        • et al.
        The dietary quality of persons with heart failure in NHANES 1999-2006.
        J Gen Intern Med. 2010; 25: 135-140
        • Hughes C.M.
        • Woodside J.V.
        • McGartland C.
        • Roberts M.J.
        • Nicholls D.P.
        • McKeown P.P.
        Nutritional intake and oxidative stress in chronic heart failure.
        Nutr Metab Cardiovasc Dis. 2012; 22: 376-382
        • Keith M.
        • Geranmayegan A.
        • Sole M.J.
        • et al.
        Increased oxidative stress in patients with congestive heart failure.
        J Am Coll Cardiol. 1998; 31: 1352-1356
        • Demirbag R.
        • Yilmaz R.
        • Erel O.
        • Gultekin U.
        • Asci D.
        • Elbasan Z.
        The relationship between potency of oxidative stress and severity of dilated cardiomyopathy.
        Can J Cardiol. 2005; 21: 851-855
        • Remme W.J.
        • Swedberg K.
        • Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology
        Guidelines for the diagnosis and treatment of chronic heart failure.
        Eur Heart J. 2001; 22: 1527-1560
        • Hornig B.
        • Arakawa N.
        • Kohler C.
        • Drexler H.
        Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure.
        Circulation. 1998; 97: 363-368
        • Patel S.
        • Celermajer D.S.
        Assessment of vascular disease using arterial flow mediated dilatation.
        Pharmacol Rep. 2006; 58: 3-7
        • Ellis G.R.
        • Anderson R.A.
        • Lang D.
        • et al.
        Neutrophil superoxide anion—Generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy.
        J Am Coll Cardiol. 2000; 36: 1474-1482
        • Ellis G.R.
        • Anderson R.A.
        • Chirkov Y.Y.
        • et al.
        Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure.
        J Cardiovasc Pharmacol. 2001; 37: 564-570
        • Erbs S.
        • Gielen S.
        • Linke A.
        • et al.
        Improvement of peripheral endothelial dysfunction by acute vitamin C application: Different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
        Am Heart J. 2003; 146: 280-285
        • Piccirillo G.
        • Nocco M.
        • Moise A.
        • et al.
        Influence of vitamin C on baroreflex sensitivity in chronic heart failure.
        Hypertension. 2003; 41: 1240-1245
        • Mak S.
        • Overgaard C.B.
        • Newton G.E.
        Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
        Am J Physiol Heart Circ Physiol. 2005; 289: H2424-H2428
        • Shinke T.
        • Shite J.
        • Takaoka H.
        • et al.
        Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
        Am Heart J. 2007; 154: 645.e1-645.e8
        • Ghatak A.
        • Brar M.J.
        • Agarwal A.
        • et al.
        Oxy free radical system in heart failure and therapeutic role of oral vitamin E.
        Int J Cardiol. 1996; 57: 119-127
        • Ho K.K.
        • Pinsky J.L.
        • Kannel W.B.
        • Levy D.
        The epidemiology of heart failure: The Framingham Study.
        J Am Coll Cardiol. 1993; 22: 6A-13A
        • Yusuf S.
        • Dagenais G.
        • Pogue J.
        • Bosch J.
        • Sleight P.
        Vitamin E supplementation and cardiovascular events in high-risk patients.
        N Engl J Med. 2000; 342: 154-160
        • Lonn E.
        • Bosch J.
        • Yusuf S.
        • et al.
        Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial.
        JAMA. 2005; 293: 1338-1347
        • Marchioli R.
        • Levantesi G.
        • Macchia A.
        • et al.
        Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
        J Cardiovasc Med (Hagerstown). 2006; 7: 347-350
        • Keith M.E.
        • Jeejeebhoy K.N.
        • Langer A.
        • et al.
        A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure.
        Am J Clin Nutr. 2001; 73: 219-224
        • Mendoza C.E.
        • Rodriguez F.
        • Rosenberg D.G.
        Reversal of refractory congestive heart failure after thiamine supplementation: Report of a case and review of literature.
        J Cardiovasc Pharmacol Ther. 2003; 8: 313-316
        • Seligmann H.
        • Halkin H.
        • Rauchfleisch S.
        • et al.
        Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: A pilot study.
        Am J Med. 1991; 91: 151-155
        • Kwok T.
        • Falconer-Smith J.F.
        • Potter J.F.
        • Ives D.R.
        Thiamine status of elderly patients with cardiac failure.
        Age Ageing. 1992; 21: 67-71
        • Pfitzenmeyer P.
        • Guilland J.C.
        • d'Athis P.
        • Petit-Marnier C.
        • Gaudet M.
        Thiamine status of elderly patients with cardiac failure including the effects of supplementation.
        Int J Vitam Nutr Res. 1994; 64: 113-118
        • Brady J.A.
        • Rock C.L.
        • Horneffer M.R.
        Thiamin status, diuretic medications, and the management of congestive heart failure.
        J Am Diet Assoc. 1995; 95: 541-544
        • Yue Q.Y.
        • Beermann B.
        • Lindstrom B.
        • Nyquist O.
        No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure.
        J Intern Med. 1997; 242: 491-495
        • da Cunha S.
        • Albanesi Filho F.M.
        • da Cunha Bastos V.L.
        • Antelo D.S.
        • Souza M.M.
        Thiamin, selenium, and copper levels in patients with idiopathic dilated cardiomyopathy taking diuretics.
        Arq Bras Cardiol. 2002; 79: 454-465
        • Zenuk C.
        • Healey J.
        • Donnelly J.
        • Vaillancourt R.
        • Almalki Y.
        • Smith S.
        Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
        Can J Clin Pharmacol. 2003; 10: 184-188
        • Hanninen S.A.
        • Darling P.B.
        • Sole M.J.
        • Barr A.
        • Keith M.E.
        The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure.
        J Am Coll Cardiol. 2006; 47: 354-361
        • Abou-Hashem R.M.
        • Maamoun M.M.
        • Hamza S.A.
        • Fahmy H.M.
        • Mortagy A.K.
        Thiamine level in hospitalized elderly Egyptian patients with congestive heart failure and left ventricular systolic dysfunction.
        J Am Geriatr Soc. 2009; 57: 2165-2166
        • Shimon I.
        • Almog S.
        • Vered Z.
        • et al.
        Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy.
        Am J Med. 1995; 98: 485-490
        • Keith M.E.
        • Walsh N.A.
        • Darling P.B.
        • et al.
        B-vitamin deficiency in hospitalized patients with heart failure.
        J Am Diet Assoc. 2009; 109: 1406-1410
        • Herzlich B.C.
        • Lichstein E.
        • Schulhoff N.
        • et al.
        Relationship among homocyst(e)ine, vitamin B-12 and cardiac disease in the elderly: Association between vitamin B-12 deficiency and decreased left ventricular ejection fraction.
        J Nutr. 1996; 126: 1249S-1253S
        • Herrmann M.
        • Muller S.
        • Kindermann I.
        • et al.
        Plasma B vitamins and their relation to the severity of chronic heart failure.
        Am J Clin Nutr. 2007; 85: 117-123
        • Daniels L.B.
        • Maisel A.S.
        Natriuretic peptides.
        J Am Coll Cardiol. 2007; 50: 2357-2368
        • Witte K.K.
        • Desilva R.
        • Chattopadhyay S.
        • Ghosh J.
        • Cleland J.G.
        • Clark A.L.
        Are hematinic deficiencies the cause of anemia in chronic heart failure?.
        Am Heart J. 2004; 147: 924-930
        • Andersson S.E.
        • Edvinsson M.L.
        • Edvinsson L.
        Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity.
        Basic Clin Pharmacol Toxicol. 2005; 97: 306-310
        • Shane E.
        • Mancini D.
        • Aaronson K.
        • et al.
        Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure.
        Am J Med. 1997; 103: 197-207
        • Pilz S.
        • Marz W.
        • Wellnitz B.
        • et al.
        Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.
        J Clin Endocrinol Metab. 2008; 93: 3927-3935
        • Zittermann A.
        • Schleithoff S.S.
        • Tenderich G.
        • Berthold H.K.
        • Korfer R.
        • Stehle P.
        Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure?.
        J Am Coll Cardiol. 2003; 41: 105-112
        • Zittermann A.
        • Schleithoff S.S.
        • Gotting C.
        • et al.
        Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.
        Eur J Heart Fail. 2008; 10: 321-327
        • Ameri P.
        • Ronco D.
        • Casu M.
        • et al.
        High prevalence of vitamin D deficiency and its association with left ventricular dilation: An echocardiography study in elderly patients with chronic heart failure.
        Nutr Metab Cardiovasc Dis. 2010; 20: 633-640
        • Iqbal N.
        • Ducharme J.
        • Desai S.
        • et al.
        Status of bone mineral density in patients selected for cardiac transplantation.
        Endocr Pract. 2008; 14: 704-712
        • Alsafwah S.
        • Laguardia S.P.
        • Nelson M.D.
        • et al.
        Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure.
        Am J Med Sci. 2008; 335: 292-297
        • Arroyo M.
        • Laguardia S.P.
        • Bhattacharya S.K.
        • et al.
        Micronutrients in African-Americans with decompensated and compensated heart failure.
        Transl Res. 2006; 148: 301-308
        • Laguardia S.P.
        • Dockery B.K.
        • Bhattacharya S.K.
        • Nelson M.D.
        • Carbone L.D.
        • Weber K.T.
        Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure.
        Am J Med Sci. 2006; 332: 112-118
        • Abou-Raya S.
        • Abou-Raya A.
        Osteoporosis and congestive heart failure (CHF) in the elderly patient: Double disease burden.
        Arch Gerontol Geriatr. 2009; 49: 250-254
        • Garakyaraghi M.
        • Kerdegari M.
        • Siavash M.
        Calcium and vitamin D status in heart failure patients in Isfahan, Iran.
        Biol Trace Elem Res. 2010; 135: 67-73
        • Kim D.H.
        • Sabour S.
        • Sagar U.N.
        • Adams S.
        • Whellan D.J.
        Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004).
        Am J Cardiol. 2008; 102: 1540-1544
        • Anderson J.L.
        • May H.T.
        • Horne B.D.
        • et al.
        Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population.
        Am J Cardiol. 2010; 106: 963-968
        • Bolland M.J.
        • Bacon C.J.
        • Horne A.M.
        • et al.
        Vitamin D insufficiency and health outcomes over 5 y in older women.
        Am J Clin Nutr. 2010; 91: 82-89
        • Boxer R.S.
        • Dauser D.A.
        • Walsh S.J.
        • Hager W.D.
        • Kenny A.M.
        The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure.
        J Am Geriatr Soc. 2008; 56: 454-461
        • Boxer R.S.
        • Kenny A.M.
        • Cheruvu V.K.
        • Vest M.
        • Fiutem J.J.
        • Pina I.I.
        Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure.
        Am Heart J. 2010; 160: 893-899
        • McGonigle R.J.
        • Timmis A.D.
        • Keenan J.
        • Jewitt D.E.
        • Weston M.J.
        • Parsons V.
        The influence of 1 alpha-hydroxycholecalciferol on left ventricular function in end-stage renal failure.
        Proc Eur Dial Transplant Assoc. 1981; 18: 579-585
        • Schleithoff S.S.
        • Zittermann A.
        • Tenderich G.
        • Berthold H.K.
        • Stehle P.
        • Koerfer R.
        Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial.
        Am J Clin Nutr. 2006; 83: 754-759
        • Witham M.D.
        • Crighton L.J.
        • Gillespie N.D.
        • Struthers A.D.
        • McMurdo M.E.
        The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: A randomized controlled trial.
        Circ Heart Fail. 2010; 3: 195-201
        • Hsia J.
        • Heiss G.
        • Ren H.
        • et al.
        Calcium/vitamin D supplementation and cardiovascular events.
        Circulation. 2007; 115: 846-854
        • Vieth R.
        Vitamin D toxicity, policy, and science.
        J Bone Miner Res. 2007; 22: V64-V68
        • Edelson G.W.
        • Kleerekoper M.
        Hypercalcemic crisis.
        Med Clin North Am. 1995; 79: 79-92
        • Lowe H.
        • Cusano N.E.
        • Binkley N.
        • Blaner W.S.
        • Bilezikian J.P.
        Vitamin D toxicity due to a commonly available “over the counter” remedy from the Dominican Republic.
        J Clin Endocrinol Metab. 2011; 96: 291-295
      1. Ross A.C. Taylor C.L. Yaktine A.L. Del Valle H.B. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press, Washington, DC2011
        • Ge K.
        • Yang G.
        The epidemiology of selenium deficiency in the etiological study of endemic diseases in China.
        Am J Clin Nutr. 1993; 57: 259S-263S
        • Oster O.
        • Prellwitz W.
        • Kasper W.
        • Meinertz T.
        Congestive cardiomyopathy and the selenium content of serum.
        Clin Chim Acta. 1983; 128: 125-132
        • Cenac A.
        • Simonoff M.
        • Djibo A.
        Nutritional status and plasma trace elements in peripartum cardiomyopathy.
        J Cardiovasc Risk. 1996; 3: 483-487
        • Chou H.T.
        • Yang H.L.
        • Tsou S.S.
        • Ho R.K.
        • Pai P.Y.
        • Hsu H.B.
        Status of trace elements in patients with idiopathic dilated cardiomyopathy in central Taiwan.
        Zhonghua Yi Xue Za Zhi (Taipei). 1998; 61: 193-198
        • Navarro-Alarcon M.
        • Lopez-Garcia de la Serrana H.
        • Perez-Valero V.
        • Lopez-Martinez C.
        Serum and urine selenium concentrations in patients with cardiovascular diseases and relationship to other nutritional indexes.
        Ann Nutr Metab. 1999; 43: 30-36
        • Raines D.A.
        • Kinsara A.J.
        • Eid Fawzy M.
        • et al.
        Plasma and urinary selenium in Saudi Arabian patients with dilated cardiomyopathy.
        Biol Trace Elem Res. 1999; 69: 59-68
        • Kosar F.
        • Sahin I.
        • Taskapan C.
        • et al.
        Trace element status (Se, Zn, Cu) in heart failure.
        Anadolu Kardiyol Derg. 2006; 6: 216-220
        • Oster O.
        Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy.
        Clin Chim Acta. 1993; 214: 209-218
        • Golik A.
        • Cohen N.
        • Ramot Y.
        • et al.
        Type II diabetes mellitus, congestive heart failure, and zinc metabolism.
        Biol Trace Elem Res. 1993; 39: 171-175
        • Ripa S.
        • Ripa R.
        • Giustiniani S.
        Are failured cardiomyopathies a zinc-deficit related disease?.
        Minerva Med. 1998; 89: 397-403
        • Topuzoglu G.
        • Erbay A.R.
        • Karul A.B.
        • Yensel N.
        Concentrations of copper, zinc, and magnesium in sera from patients with idiopathic dilated cardiomyopathy.
        Biol Trace Elem Res. 2003; 95: 11-17
        • Salehifar E.
        • Shokrzadeh M.
        • Ghaemian A.
        • Aliakbari S.
        • Saeedi Saravi S.S.
        The study of Cu and Zn serum levels in idiopathic dilated cardiomyopathy (IDCMP) patients and its comparison with healthy volunteers.
        Biol Trace Elem Res. 2008; 125: 97-108
        • Shokrzadeh M.
        • Ghaemian A.
        • Salehifar E.
        • Aliakbari S.
        • Saravi S.S.
        • Ebrahimi P.
        Serum zinc and copper levels in ischemic cardiomyopathy.
        Biol Trace Elem Res. 2009; 127: 116-123
        • Malek F.
        • Dvorak J.
        • Jiresova E.
        • Spacek R.
        Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure.
        Cent Eur J Public Health. 2003; 11: 198-201
        • Jeejeebhoy F.
        • Keith M.
        • Freeman M.
        • et al.
        Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction.
        Am Heart J. 2002; 143: 1092-1100
        • Witte K.K.
        • Nikitin N.P.
        • Parker A.C.
        • et al.
        The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.
        Eur Heart J. 2005; 26: 2238-2244
        • Lennie T.A.
        • Moser D.K.
        • Heo S.
        • Chung M.L.
        • Zambroski C.H.
        Factors influencing food intake in patients with heart failure: A comparison with healthy elders.
        J Cardiovasc Nurs. 2006; 21: 123-129
        • King D.
        • Smith M.L.
        • Chapman T.J.
        • Stockdale H.R.
        • Lye M.
        Fat malabsorption in elderly patients with cardiac cachexia.
        Age Ageing. 1996; 25: 144-149
        • Koren-Michowitz M.
        • Dishy V.
        • Zaidenstein R.
        • et al.
        The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: A prospective open-label study.
        Am J Hypertens. 2005; 18: 358-363
        • Witte K.K.
        • Clark A.L.
        Micronutrients and their supplementation in chronic cardiac failure.
        Heart Fail Rev. 2006; 11: 65-74
        • Weber K.T.
        • Weglicki W.B.
        • Simpson R.U.
        Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium.
        Cardiovasc Res. 2009; 81: 500-508
        • Nemerovski C.W.
        • Dorsch M.P.
        • Simpson R.U.
        • Bone H.G.
        • Aaronson K.D.
        • Bleske B.E.
        Vitamin D and cardiovascular disease.
        Pharmacotherapy. 2009; 29: 691-708
        • Sociedade Brasileira de Cardiologia
        Review of the II Guidelines of the Sociedade Brasileira de Cardiologia for the diagnosis and treatment of heart failure.
        Arq Bras Cardiol. 2002; 79: 1-30
        • Richardson P.
        • McKenna W.
        • Bristow M.
        • et al.
        Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
        Circulation. 1996; 93: 841-842
        • Goodwin J.F.
        • Oakley C.M.
        The cardiomyopathies.
        Br Heart J. 1972; 34: 545-552

      Biography

      N. A. McKeag is a clinical research fellow, Centre for Public Health, Queen's University Belfast, Institute of Clinical Science B, Belfast, United Kingdom.

      Biography

      M. C. McKinley is a senior lecturer, Centre for Public Health, Queen's University Belfast, Institute of Clinical Science B, Belfast, United Kingdom.

      Biography

      J. V. Woodside is a reader, Centre for Public Health, Queen's University Belfast, Institute of Clinical Science B, Belfast, United Kingdom.

      Biography

      P. P. McKeown is a senior lecturer, Centre for Public Health, Queen's University Belfast, Institute of Clinical Science B, Belfast, United Kingdom.

      Biography

      M. T. Harbinson is a senior lecturer, Centre for Vision and Vascular Sciences, Queen's University Belfast, Institute of Clinical Science A, Belfast, United Kingdom.